Protagenic Therapeutics (PTIX) — Cash Flow-to-Debt Ratio
Protagenic Therapeutics (PTIX) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of $-410.42K could theoretically repay 0% of its total liabilities ($6.82 Million) in one year. See PTIX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Protagenic Therapeutics Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Protagenic Therapeutics across 31 annual periods. For the full cash flow conversion analysis, see how efficiently does Protagenic Therapeutics generate cash.
Annual Cash Flow-to-Debt Ratio for Protagenic Therapeutics (1995–2025)
Year-by-year debt coverage analysis for Protagenic Therapeutics. Check PTIX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | $-4.14 Million | $6.82 Million | ▲ +86.4% |
| 2024 | -4.47x | $-4.22 Million | $942.76K | ▲ +20.9% |
| 2023 | -5.65x | $-3.70 Million | $655.25K | ▼ -217.5% |
| 2022 | -1.78x | $-1.99 Million | $1.12 Million | ▲ +28.9% |
| 2021 | -2.50x | $-2.80 Million | $1.12 Million | ▼ -276.6% |
| 2020 | -0.66x | $-1.35 Million | $2.03 Million | ▼ -101.2% |
| 2019 | -0.33x | $-487.99K | $1.48 Million | ▲ +72.0% |
| 2018 | -1.18x | $-1.07 Million | $907.77K | ▲ +52.0% |
| 2017 | -2.46x | $-1.38 Million | $561.69K | ▼ -47.6% |
| 2016 | -1.67x | $-1.14 Million | $684.86K | ▼ -210.1% |
| 2015 | -0.54x | $-378.00K | $704.00K | ▲ +10.5% |
| 2015 | -0.60x | $-378.00K | $630.00K | ▲ +76.0% |
| 2014 | -2.50x | $-790.00K | $316.00K | ▲ +0.0% |
| 2013 | -2.50x | $-790.00K | $316.00K | ▼ -13927.8% |
| 2012 | -0.02x | $-324.00K | $18.18 Million | ▲ +98.2% |
| 2010 | -1.01x | $-11.25 Million | $11.17 Million | ▼ -543.1% |
| 2009 | -0.16x | $-3.02 Million | $19.25 Million | ▼ -186.7% |
| 2008 | 0.18x | $4.36 Million | $24.11 Million | ▲ +124.6% |
| 2007 | -0.73x | $-5.21 Million | $7.10 Million | ▼ -436.7% |
| 2006 | 0.22x | $931.00K | $4.27 Million | ▲ +146.8% |
| 2005 | -0.47x | $-44.00K | $94.47K | ▼ -133.2% |
| 2004 | -0.20x | $-842.00K | $4.21 Million | ▼ -193.6% |
| 2003 | 0.21x | $1.87 Million | $8.76 Million | ▼ -21.2% |
| 2002 | 0.27x | $2.35 Million | $8.65 Million | ▲ +74.9% |
| 2001 | 0.15x | $1.50 Million | $9.71 Million | ▼ -60.0% |
| 2000 | 0.39x | $3.51 Million | $9.06 Million | ▲ +1029.6% |
| 1999 | 0.03x | $331.00K | $9.66 Million | ▲ +159.5% |
| 1998 | -0.06x | $-434.00K | $7.53 Million | ▲ +93.5% |
| 1997 | -0.89x | $-2.20 Million | $2.47 Million | ▼ -2042.5% |
| 1996 | -0.04x | $-230.00K | $5.53 Million | ▲ +75.3% |
| 1995 | -0.17x | $-600.00K | $3.57 Million | — |